IDO1 and cancer: Nevertheless, experimental evidence supporting the rationale for using IDO1 as a drug target for cancer therapy would be welcome irrespective of whether it is the immune-cell IDO1 or the cancer-cell IDO1 that elicits the therapeutic effect.